Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer.
androgen receptor
biomarkers
castration resistance
metabolomics
metastasis
prostate cancer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Jan 2023
04 Jan 2023
Historique:
received:
11
12
2022
revised:
30
12
2022
accepted:
01
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid glycolytic/oxidative phosphorylation phenotype determined by androgen receptor signaling. An increased lipogenesis and cholesterogenesis have been described in PCa cells. Many studies have shown that enzymes involved in these pathways are overexpressed in PCa. Glutamine becomes an essential amino acid for PCa cells, and its metabolism is thought to become an attractive therapeutic target. A crosstalk between cancer and stromal cells occurs in the tumor microenvironment because of the release of different cytokines and growth factors and due to changes in the extracellular matrix. A deeper insight into the metabolic changes may be obtained by a multi-omic approach integrating genomics, transcriptomics, metabolomics, lipidomics, and radiomics data.
Identifiants
pubmed: 36674430
pii: ijms24020910
doi: 10.3390/ijms24020910
pmc: PMC9863674
pii:
doi:
Substances chimiques
Receptors, Androgen
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Cancer Res. 2009 Jan 15;15(2):431-40
pubmed: 19147747
J Biol Chem. 2015 Aug 21;290(34):20734-20742
pubmed: 26152727
J Biol Inorg Chem. 2011 Jan;16(1):3-8
pubmed: 21140181
BMC Med. 2022 Aug 18;20(1):255
pubmed: 35978404
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657335
Nat Rev Urol. 2013 Apr;10(4):219-26
pubmed: 23478540
Mod Pathol. 2011 Sep;24(9):1272-80
pubmed: 21572396
Medicine (Baltimore). 2014 Dec;93(27):e183
pubmed: 25501064
Magn Reson Med. 2008 Jul;60(1):33-40
pubmed: 18581409
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
Cancer Discov. 2012 Apr;2(4):328-43
pubmed: 22576210
PLoS One. 2012;7(6):e39445
pubmed: 22761797
J Hum Reprod Sci. 2021 Apr-Jun;14(2):129-136
pubmed: 34316227
J Biol Chem. 2001 Jun 22;276(25):22258-64
pubmed: 11301334
Am J Physiol Cell Physiol. 2009 Nov;297(5):C1188-99
pubmed: 19657064
Biochem J. 2011 Jan 1;433(1):225-33
pubmed: 20958264
J Pharmacol Exp Ther. 2011 Feb;336(2):496-505
pubmed: 21059805
Cancer Lett. 2016 Jun 28;376(1):1-9
pubmed: 26996298
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
Sci Transl Med. 2019 Feb 6;11(478):
pubmed: 30728288
Oncogene. 2022 May;41(20):2798-2810
pubmed: 35411033
Nat Commun. 2016 Jan 12;7:10230
pubmed: 26756352
J Biol Chem. 1998 Feb 27;273(9):5053-9
pubmed: 9478955
Front Immunol. 2017 Jul 14;8:828
pubmed: 28769933
Prog Lipid Res. 2001 Nov;40(6):439-52
pubmed: 11591434
World J Urol. 2019 Mar;37(3):507-514
pubmed: 29992381
Clin Cancer Res. 2012 Nov 1;18(21):5888-901
pubmed: 23072969
Mol Oncol. 2020 Dec;14(12):3100-3120
pubmed: 33031638
Cancer Res. 2021 Jan 1;81(1):50-63
pubmed: 33115805
Cancer Lett. 2020 Feb 28;471:72-87
pubmed: 31838085
Oncogene. 2014 Nov 6;33(45):5251-61
pubmed: 24186207
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Urol Oncol. 2015 Nov;33(11):494.e1-7
pubmed: 26278366
Prostate. 2012 Nov;72(15):1611-21
pubmed: 22430630
Chem Phys Lipids. 2016 May;197:45-59
pubmed: 26200918
Int J Cancer. 2009 Mar 15;124(6):1398-403
pubmed: 19058180
Trends Mol Med. 2014 Aug;20(8):428-36
pubmed: 24836411
Cancer. 2007 Feb 15;109(4):675-84
pubmed: 17211863
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
PLoS One. 2009 Dec 30;4(12):e8496
pubmed: 20041144
Oncotarget. 2015 May 30;6(15):13371-86
pubmed: 25945836
J Cell Biochem. 2012 Feb;113(2):553-62
pubmed: 21938742
Autophagy. 2021 Nov;17(11):3879-3881
pubmed: 34486482
Cancer Lett. 2004 Apr 15;207(1):79-87
pubmed: 15050736
Epidemiol Rev. 2007;29:88-97
pubmed: 17478439
Cells. 2020 Sep 03;9(9):
pubmed: 32899180
BJU Int. 2012 Aug;110(4):492-8
pubmed: 22094083
Mol Cancer Res. 2021 Mar;19(3):475-484
pubmed: 33168599
Eur J Pharmacol. 2011 Dec 30;673(1-3):96-100
pubmed: 22040920
Expert Rev Mol Diagn. 2015;15(9):1211-24
pubmed: 26174441
Am J Clin Exp Urol. 2014 Jul 12;2(2):111-20
pubmed: 25374912
Front Immunol. 2017 Aug 09;8:939
pubmed: 28848547
Nat Metab. 2019 Jan;1(1):70-85
pubmed: 31198906
Nature. 2005 Feb 3;433(7025):523-7
pubmed: 15690042
Cell Cycle. 2010 Mar 15;9(6):1091-6
pubmed: 20190568
Mol Cancer. 2007 Jun 05;6:37
pubmed: 17550612
Int J Mol Sci. 2022 Aug 06;23(15):
pubmed: 35955892
Sci Rep. 2016 Feb 11;6:20984
pubmed: 26865432
Elife. 2020 Jul 20;9:
pubmed: 32686647
Autophagy. 2015 Nov 2;11(11):2102-2113
pubmed: 26391455
Mol Metab. 2022 Aug;62:101516
pubmed: 35598879
Urol Oncol. 2017 Jul;35(7):461.e15-461.e27
pubmed: 28359744
Mol Cancer. 2006 May 15;5:17
pubmed: 16700911
J Urol. 2009 Oct;182(4):1621-7
pubmed: 19683746
Gene. 2018 Nov 15;676:171-183
pubmed: 30021130
Cancer Sci. 2011 Mar;102(3):501-8
pubmed: 21205077
Nat Med. 2004 Jun;10(6):594-601
pubmed: 15156201
J Urol. 2013 Dec;190(6):2271-7
pubmed: 23665271
Int J Oncol. 2020 May;56(5):1152-1161
pubmed: 32319589
Prostate. 2002 Sep 1;52(4):311-8
pubmed: 12210492
Cancer Res. 2012 Oct 1;72(19):5130-40
pubmed: 22850421
Biochem Biophys Res Commun. 2015 Jan 2;456(1):452-8
pubmed: 25482439
J Clin Invest. 2018 Oct 1;128(10):4472-4484
pubmed: 30047926
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18782-7
pubmed: 19033189
Expert Rev Mol Diagn. 2019 May;19(5):377-387
pubmed: 30957583
Cell Signal. 2021 Nov;87:110119
pubmed: 34418535
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
Mol Cancer. 2006 Apr 04;5:14
pubmed: 16595004
Future Oncol. 2017 Feb;13(3):285-293
pubmed: 27624840
J Transl Med. 2020 Dec 9;18(1):472
pubmed: 33298113
Endocrinol Diabetes Metab. 2018 Jan 18;1(2):e00010
pubmed: 30815547
Future Oncol. 2013 Jun;9(6):899-907
pubmed: 23718310
Cold Spring Harb Symp Quant Biol. 2016;81:73-78
pubmed: 28209717
J Biol Chem. 1999 Jun 18;274(25):17499-504
pubmed: 10364181
Int J Cancer. 2014 Dec 1;135(11):2558-68
pubmed: 24740818
J Med Internet Res. 2021 Apr 1;23(4):e22394
pubmed: 33792552
Oncogene. 2022 Feb;41(8):1190-1202
pubmed: 35067686
Prostate. 2008 Sep 15;68(13):1443-9
pubmed: 18615482
Semin Cancer Biol. 2022 Jul;82:94-119
pubmed: 33290846
Cancers (Basel). 2022 Jan 25;14(3):
pubmed: 35158864
Cancers (Basel). 2022 Jun 12;14(12):
pubmed: 35740569
J Androl. 2005 Jul-Aug;26(4):459-69
pubmed: 15955884
Cancer Res. 2017 Sep 15;77(18):5158-5168
pubmed: 28687617
Cell Death Differ. 2009 Sep;16(9):1203-14
pubmed: 19343039
Cell Metab. 2019 Feb 5;29(2):488-500.e2
pubmed: 30318341
Oncogenesis. 2014 May 26;3:e103
pubmed: 24861463
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):7999-8004
pubmed: 28696297
Carcinogenesis. 2006 Oct;27(10):1980-90
pubmed: 16606632
Endocr Relat Cancer. 2014 May 06;21(3):R143-52
pubmed: 24659477
Cell Rep. 2019 Apr 9;27(2):491-501.e6
pubmed: 30970252
J Pathol. 2015 Jul;236(3):278-89
pubmed: 25693838
Biomed Pharmacother. 2020 Mar;123:109666
pubmed: 31935634
Cytokine Growth Factor Rev. 2017 Feb;33:65-72
pubmed: 27769579
Int J Mol Sci. 2022 Mar 30;23(7):
pubmed: 35409187
Oncogene. 2019 Jul;38(27):5339-5355
pubmed: 30936458
Oncogene. 2021 Mar;40(9):1690-1705
pubmed: 33531625
Cancers (Basel). 2020 Dec 18;12(12):
pubmed: 33352874
Biochim Biophys Acta. 2014 Aug;1846(1):99-112
pubmed: 24727384
Prostate. 1999 Aug 1;40(3):200-7
pubmed: 10398282
Int J Cancer. 2017 Sep 1;141(5):933-944
pubmed: 28543830
Mol Cancer Res. 2012 Jan;10(1):133-42
pubmed: 22064655
Nat Rev Cancer. 2011 Nov 17;11(12):835-48
pubmed: 22089420
Front Oncol. 2017 Dec 11;7:306
pubmed: 29376023
Clin Cancer Res. 2015 Dec 15;21(24):5434-8
pubmed: 26519059
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):88-94
pubmed: 18199714
Nature. 2015 Feb 19;518(7539):413-6
pubmed: 25487152
Ther Adv Urol. 2022 Jul 4;14:17562872221109020
pubmed: 35814914
Mol Urol. 2000 Spring;4(1):31-6
pubmed: 10851304
Mitochondrion. 2005 Jun;5(3):143-53
pubmed: 16050980
Nat Rev Mol Cell Biol. 2012 Apr 04;13(5):283-96
pubmed: 22473468
Cancer Res. 2018 Aug 15;78(16):4459-4470
pubmed: 29891507
Int J Mol Sci. 2021 Sep 15;22(18):
pubmed: 34576134
Curr Med Chem. 2006;13(10):1169-86
pubmed: 16719778
Int J Fertil Steril. 2019 Jan;12(4):267-272
pubmed: 30291684
World J Urol. 2015 Jan;33(1):1-7
pubmed: 24504760
Cancer Res. 2008 Apr 1;68(7):2223-32
pubmed: 18381428
Cancers (Basel). 2022 Sep 01;14(17):
pubmed: 36077824
Mol Cancer Res. 2019 Mar;17(3):821-835
pubmed: 30606769
J Urol. 2013 Dec;190(6):2061-6
pubmed: 23820055
Mol Cancer Res. 2017 Aug;15(8):1017-1028
pubmed: 28507054
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640
pubmed: 30578319
J Biol Chem. 2000 Feb 25;275(8):5560-4
pubmed: 10681536
Nature. 2009 Apr 9;458(7239):762-5
pubmed: 19219026
Prostate. 2009 Jun 15;69(9):1017-23
pubmed: 19301305
Free Radic Biol Med. 2012 Aug 1;53(3):421-36
pubmed: 22580150